Health
Inhibition of Meprin Β enzyme can trigger the development of Alzheimer’s disease, cancer – News-Medical.Net
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma…
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.
These results could lead to the development of new drugs to treat serious diseases such as Alzheimer’s and cancer. Meprin β releases proteins from cell membranes, thus controlling important physiological functions in the human body.
…
-
Noosa News22 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business24 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Business19 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
General24 hours agoLike ‘déjà vu’ all over again?